Evidence map›Paper›PMID 37502424›Full record

ArticleFrontiers in aging neuroscience2023

Effects of human probiotics on memory and psychological and physical measures in community-dwelling older adults with normal and mildly impaired cognition: results of a bi-center, double-blind, randomized, and placebo-controlled clinical trial (CleverAge biota).

Ales Bartos, Josefina Weinerova, Sofia Diondet

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05051501 phase2completednot on this map

Biotechnology Research Into Microbiological Spectrum Changes to Improve Cognitive Functions, Depression and Other Neuropsychiatric Disorders in Aging Population

TypeinterventionalSponsorNational Institute of Mental Health, Czech RepublicRan2021 to 2022Enrolled90ConditionsMemory Deficits, Mood Change, Gut Health, Aging ProblemsArmsProbiotics C2P
NCT06670716 unknown statusnot on this mapstarted 2024, after this paper: background citation

VERY BRIEF SPEECH and MEMORY ASSESSMENTS USING ALBA a PICNIR TESTS and DELIRIUM ASSESSMENTS USING CAM-ICU and ICDSC TESTS in PATIENTS SHORTLY AFTER the STROKE

Typeobservational_patient_registrySponsorFaculty Hospital Kralovske VinohradyRan2024 to 2026Enrolled60ConditionsStroke AcuteArmsExamination by a speech therapist, Cognitive examination, Examination of delirium, History taking
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Observational
  6. Article
  7. Review
  8. The therapeutic potential ofFrontiers in microbiology · 2026
    Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ales BartosDepartment of Neurology, Third Faculty of Medicine, Charles University, Prague, Czechia.
Josefina WeinerovaNational Institute of Mental Health, Klecany, Czechia.
Sofia DiondetFirst Faculty of Medicine, Charles University, Prague, Czechia.
Charles University · CZNational Institute of Public Health · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study presents results of our randomized clinical trial studying the effect of human probiotics on memory and psychological and physical measures following our study protocol registered at clinicaltrials.gov NCT05051501 and described in detail in our previous paper. Methods: Community dwelling participants aged between 55 and 80  years were randomly assigned to receive a single dose of 10 Results: At baseline, the probiotic-placebo group A ( Conclusion: The treatment with human probiotics and prebiotics did not improve cognitive, affective, or physical measures in community-dwelling individuals with normal or mildly impaired cognitive functions. Clinical trial registration: clinicaltrials.gov, identifier NCT05051501.

Indexed as

Alzheimer diseaseclinicaltrials.gov NCT05051501cognitive impairmentdepressiongut microbiotamemoryprobiotics

Identifiers

PMID37502424
PMCPMC10369778
OpenAlexW4383555126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.